Product References
Exosomal RNF157 mRNA from prostate cancer cells contributes to M2 macrophage polarization through destabilizing HDAC1.
Frontiers in oncology
Guan H,Mao L,Wang J,Wang S,Yang S,Wu H,Sun W,Chen Z,Chen M
49-1025 was used in Western Blot to investigate the role of exosomal RNF157 mRNA in prostate cancer development.
Fri Oct 21 00:00:00 UTC 2022
Exosomal RNF157 mRNA from prostate cancer cells contributes to M2 macrophage polarization through destabilizing HDAC1.
Frontiers in oncology
Guan H,Mao L,Wang J,Wang S,Yang S,Wu H,Sun W,Chen Z,Chen M
49-1025 was used in Western Blot to investigate the role of exosomal RNF157 mRNA in prostate cancer development.
Fri Oct 21 00:00:00 UTC 2022
The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer.
Oncogene
Mao X,Gauche C,Coughtrie MW,Bui C,Gulberti S,Merhi-Soussi F,Ramalanjaona N,Bertin-Jung I,Diot A,Dumas D,De Freitas Caires N,Thompson AM,Bourdon JC,Ouzzine M,Fournel-Gigleux S
49-1025 was used in Chromatin immunoprecipitation to define 3-OST3A as a novel regulator of breast cancer pathogenicity, displaying tumor-suppressive or oncogenic activities in a cell- and tumor-dependent context, and demonstrate the clinical value of the HS-O-sulfotransferase 3-OST3A as a prognostic marker in HER2+ patients.
Thu Sep 22 00:00:00 UTC 2016
Transcriptional repression of ER through hMAPK dependent histone deacetylation by class I HDACs.
Breast cancer research and treatment
Plotkin A,Volmar CH,Wahlestedt C,Ayad N,El-Ashry D
49-1025 was used in western blot to study the relationship between hyperactivation of MAPK and the estrogen receptor in breast cancer cells
Mon Sep 01 00:00:00 UTC 2014